Keywords: Immunoassay; Pregnancy; Placental growth factor (PlGF); Soluble fms-like tyrosine kinase 1 (sFlt-1); sFlt-1:PlGF ratio; Pre-eclampsia; Hypertensive disorders;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Pregnancy; Placenta; Angiogenesis; Anemia; Vascular endothelial growth factor (VEGF); Placental growth factor (PlGF); Hypoxia;
Keywords: Aspirin; MFMU; Placental growth factor (PlGF); Preeclampsia;
Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity
Keywords: fms-like tyrosine kinase-1 (sFlt-1); insulin resistance; large for gestational age (LGA); mTOR; macrosomia; mitochondria; nutritional sensing; obesity; placental growth factor (PlGF); soluble endoglin (sEng); soluble vascular endothelial growth factor rec
Impact du retard de croissance intra-utérin sur la concentration sérique maternelle du PlGF (Placental Growth Factor) : une étude cas-témoin
Keywords: Retard de croissance intra-utérin (RCIU); Test diagnostique; Marqueur biochimique; Placental Growth Factor (PlGF)Intra-uterine growth restriction (IUGR); Diagnostic test; Biomarker; Placental growth factor (PlGF)
Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease
Keywords: Preeclampsia; Neuropeptide Y (NPY); Vasoconstriction; Soluble fms-like tyrosine kinase-1 (sFlt-1); Placental growth factor (PlGF); Stress;
Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats
Keywords: exendin-4; glucagon-like peptide 1 receptor; diabetic retinopathy; Goto-Kakizaki (GK) rat; blood-retinal barrier; placental growth factor (PLGF); AKT/PKB; protein kinase B; BRB; blood-retinal barrier; DR; diabetic retinopathy; EBP; Evans blue permeati
Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia
Keywords: fetal death; placental growth factor (PlGF); small-for-gestational-age (SGA); soluble endoglin (sEng); soluble vascular endothelial growth factor receptor-1 (sVEGFR-1);
Combination of uterine artery Doppler velocimetry and maternal serum placental growth factor estimation in predicting occurrence of pre-eclampsia in early second trimester pregnancy: a prospective cohort study
Keywords: Uterine artery Doppler velocimetry (UADV); Placental growth factor (PlGF); Pre-eclampsia; Odds ratio; Logistic regression analysis;
Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays
Keywords: angiogenesis; biomarker; diagnostic test; placental growth factor (PlGF); preeclampsia; soluble Fms-like tyrosine kinase-1 (sFlt-1);
Nicotine restores endothelial dysfunction caused by excess sFlt1 and sEng in an in vitro model of preeclamptic vascular endothelium: a possible therapeutic role of nicotinic acetylcholine receptor (nAChR) agonists for preeclampsia
Keywords: nicotine; placental growth factor (PlGF); preeclampsia; soluble fms-like tyrosine kinase 1 (sFlt1); soluble endoglin (sEng);
Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia
Keywords: endoglin; soluble fms-like tyrosine kinase 1 (sFlt1); preeclampsia; oxidative stress; placental growth factor (PlGF);
Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor
Keywords: gestational hypertension; placental growth factor (PlGF); preeclampsia; small for gestational age; soluble vascular endothelial growth factor receptor-1 (VEGFR-1); uterine artery Doppler velocimetry; vascular endothelial growth factor (VEGF);
Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia
Keywords: BMI; body mass index; ELISA; enzyme-linked immunosorbent assay; PlGF; placental growth factor; sFlt1; soluble fms-like tyrosine kinase 1 (also named sVEGFR-1); sVEGFR-1; soluble vascular endothelial growth factor receptor 1 (also named sFlt1); VEGF; vascu